Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,51 USD | -2,50% | +3,85% | +111,45% |
Attività
Numero di dipendenti: 28
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joel Lewis
CEO | Chief Executive Officer | 54 | 01/12/17 |
Jack Callicutt
DFI | Director of Finance/CFO | 56 | 01/07/13 |
Ezra R. lowe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Pol Boudes
CTO | Chief Tech/Sci/R&D Officer | 67 | 02/03/20 |
Harold Shlevin
BRD | Director/Board Member | 75 | 01/10/12 |
Susan Thornton
LAW | General Counsel | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Kevin Freeman
BRD | Director/Board Member | 62 | 01/05/11 |
Benjamin Carson
BRD | Director/Board Member | 73 | 07/12 |
Gil Omenn
BRD | Director/Board Member | 83 | 23/09/14 |
Gilbert Amelio
BRD | Director/Board Member | 81 | 12/02/09 |
Harold Shlevin
BRD | Director/Board Member | 75 | 01/10/12 |
Dick Uihlein
CHM | Chairman | 79 | 14/12/17 |
Marc Rubin
BRD | Director/Board Member | 69 | 12/10/11 |
Kary Eldred
BRD | Director/Board Member | 50 | 01/01/18 |
Richard Zordani
BRD | Director/Board Member | 52 | 01/09/20 |
Elissa Schwartz
BRD | Director/Board Member | 54 | 01/09/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 1 235 000 | 0 | 0 | 67,53 % |
Azione B | 1 | 61 903 672 | 42 636 943 ( 68,88 %) | 0 | |
Azione C | 0 | 176 | 0 | 0 |
Coordinate società
Galectin Therapeutics, Inc.
4960 Peachtree Industrial Boulevard Suite 240
30071, Norcross
+678 620 3186
http://www.galectintherapeutics.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+111,45% | 223 Mln | |
+0,17% | 42,86 Mrd | |
+10,92% | 42,74 Mrd | |
+44,30% | 41,36 Mrd | |
-6,20% | 27,68 Mrd | |
+5,23% | 25,15 Mrd | |
-24,79% | 18,63 Mrd | |
+26,69% | 12,37 Mrd | |
-3,13% | 11,92 Mrd | |
+6,57% | 11,21 Mrd |
- Borsa valori
- Azioni
- Azione GALT
- Società Galectin Therapeutics Inc.